Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ESAB Corporation (NYSE: ESAB) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, helping investors review how this focused industrial compounder reports its activities. ESAB is based in North Bethesda, Maryland and operates globally in heating equipment and welding-related manufacturing, serving customers in roughly 150 countries.
ESAB’s filings include current reports on Form 8-K, which cover topics such as quarterly earnings releases, material financing arrangements and governance changes. For example, ESAB has filed 8-Ks to furnish press releases reporting financial results for specific quarters, to disclose an Amended and Restated Credit Agreement that established new term loan and revolving credit facilities, and to announce the appointment of a new independent director and the planned retirement of a long-serving board member.
Investors can also use this page to access periodic reports referenced in ESAB’s communications, such as quarterly reports on Form 10-Q, which provide more detailed financial statements and management discussion. ESAB’s earnings releases point to these filings for reconciliations of GAAP to non-GAAP measures like adjusted net income, core adjusted net income, adjusted EBITDA, core adjusted EBITDA, organic sales, core organic sales and adjusted free cash flow.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, including revenue trends, margin performance, non-GAAP adjustments, acquisition impacts and covenant details in financing agreements. Users can quickly see which filings relate to topics such as credit facilities, acquisition announcements, dividend-related disclosures or board changes, and then drill into the full SEC documents for deeper review. Real-time updates from EDGAR ensure that new ESAB filings, including future 10-Q, 10-K and 8-K reports, are reflected promptly with plain-language explanations.
ESAB Corp director Martin Sebastien reported beneficial ownership of 595 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of ESAB common stock. These RSUs were granted to him in connection with consulting services previously provided to the company. The units will vest in three equal, annual installments beginning on October 1, 2026 and continuing through October 1, 2028, if the vesting conditions are met. The filing shows these RSUs are held directly.
ESAB Corp reported an equity transaction by its Chief Financial Officer on January 2, 2026. The filing shows that 986 restricted stock units (RSUs) were converted into an equal number of shares of ESAB common stock, reflecting the vesting of a prior equity award. In connection with this vesting, 537 shares of common stock were withheld by ESAB to cover the officer's tax liability at a price of $112.57 per share, and no shares were sold by the officer for this purpose.
After these transactions, the officer directly beneficially owned 26,404 shares of ESAB common stock. The RSU award referenced in the filing vests in three equal annual installments that began on January 2, 2025, with the remaining restricted stock units scheduled to vest on January 2, 2027.
ESAB Corp reported that one of its directors received 213 deferred stock units on 12/31/2025. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of the director's cash retainer for Board service, so they carry a price of $0 for this grant.
The deferred stock units vest immediately, meaning the director's right to the units is not subject to additional service conditions. However, the units will be settled in ESAB common stock only after the director separates from the company, aligning the director's compensation with the long‑term value of the stock.
ESAB Corp reported a routine equity compensation move for one of its directors. On 12/31/2025, the director received 263 deferred stock units, each representing a contingent right to receive one share of ESAB common stock. These units were issued in lieu of the director's cash retainer for Board service, effectively paying board fees in stock-based form rather than cash.
The deferred stock units vest immediately, but will only be settled in ESAB common stock after the director separates from the company. This structure aligns the director’s compensation with long-term shareholder value while deferring actual share delivery until service on the Board ends.
ESAB Corp reported that one of its directors received an equity-based award tied to board service. On 12/31/2025, the director was granted 54 deferred stock units, each representing the right to receive one share of ESAB common stock. These units were issued in lieu of the director’s cash retainer for serving on the Board.
The deferred stock units vest immediately, meaning they are fully earned on the grant date, but will be settled in ESAB common stock only after the director separates from the company. This aligns the director’s compensation more closely with ESAB’s long-term share performance without involving any open-market stock purchase or sale.
ESAB Corp reported that one of its directors received equity-based compensation in the form of deferred stock units. On 12/31/2025, the director acquired 213 deferred stock units, each representing a contingent right to receive one share of ESAB common stock with a par value of $0.001 per share.
These 213 deferred stock units were issued in lieu of the director's cash retainer for Board service, meaning the director chose stock-based pay instead of cash. The units vest immediately but will be settled in ESAB common stock only after the director separates from the company, aligning part of the director's compensation with long-term shareholder interests.
ESAB Corp director Mitchell P. Rales reported a grant of 493 shares of common stock in the form of deferred stock units on December 31, 2025, at a price of $0.00 per share. These units are payable only in common stock and will be settled after he leaves the Board, at the earlier of his death or January 31 of the second calendar year following his retirement.
After this grant, he directly holds 14,453 ESAB common shares. He also reports indirect holdings, including 3,355,765 shares through a single-member LLC, 4,816-share custodial accounts for his daughter for which he disclaims beneficial ownership, and 226,421 shares held by the Mitchell P. Rales Family Trust.
ESAB Corp reported an insider stock transaction on a Form 4 by one reporting person who serves as Officer, President, Fab Tech. On 12/15/2025, the insider reported two non-derivative transactions in ESAB common stock, each labeled with transaction code "G". Each transaction involved the disposition of 320 shares of common stock at a reported price of $0 per share. Following these transactions, the filing shows directly owned common stock holdings of 14,669 shares in one line and 14,349 shares in another line.
ESAB Corp reported a routine insider equity transaction by its Controller and PAO. On 11/24/2025, 205 restricted stock units converted into the same number of shares of common stock. To cover related tax obligations, 71 shares of common stock were withheld by ESAB Corporation at a price of $107.35 per share, and no shares were sold by the insider in the market.
After these transactions, the reporting person directly owned 8,099 shares of ESAB common stock. The underlying restricted stock unit award, which vested in three equal annual installments beginning on 11/22/2023, was fully vested as of 11/22/2025, leaving no derivative securities from this grant outstanding.
ESAB Corporation announced changes to its board of directors. The Board appointed Dr. Sébastien Martin as a director, effective January 1, 2026, and increased the Board size from nine to ten members on that date. Dr. Martin, an Associate Professor of Operations at the Kellogg School of Management, will also join the Board’s Audit Committee.
His background includes research in large-scale optimization, transportation, the gig economy, public sector operations, and artificial intelligence, and he has served as an external AI advisor to ESAB since February 2025, a role he will leave before joining the Board. ESAB states that Dr. Martin will receive its standard non-employee director compensation and enter into its customary indemnification agreement, and that he qualifies as an independent director under NYSE rules.
Separately, director Patrick Allender notified the Board of his decision to retire as a director, effective at ESAB’s 2026 annual meeting of stockholders. The company notes that his retirement is not due to any disagreement regarding ESAB’s operations, policies, or practices.